인공수정체 시장 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 고찰 및 예측(2026-2034년)

Growth Factors of intraocular lens (IOL) Market

The global intraocular lens (IOL) market was valued at USD 5.14 billion in 2025 and is projected to grow to USD 5.49 billion in 2026. The market is expected to reach USD 9.52 billion by 2034, exhibiting a CAGR of 7.13% during the forecast period (2026-2034).

North America dominated the market in 2025, accounting for a 33.76% share, supported by strong adoption of advanced ophthalmic technologies and favorable reimbursement policies.

Introduction

Intraocular lenses (IOLs) are artificial lenses implanted in the eye during cataract or glaucoma surgeries to replace the natural lens. These devices are crucial in restoring vision and improving quality of life. The increasing prevalence of cataracts and visual impairments globally is significantly driving the demand for IOLs.

Market Trends

A key trend shaping the market is the launch of advanced extended depth of focus (EDOF) lenses. These technologically advanced lenses improve vision at multiple distances and reduce dependency on glasses.

Continuous innovation and increasing clinical studies supporting advanced lens technologies are further contributing to the growth of the intraocular lens market.

Market Growth Drivers

1. Rising Prevalence of Cataracts

According to global health estimates, millions of people suffer from cataracts, making it one of the leading causes of blindness. The increasing patient pool is significantly driving demand for cataract surgeries and IOL implantation.

2. Increase in Cataract Surgeries

Cataract surgery is one of the most commonly performed surgical procedures worldwide. For instance, millions of surgeries are conducted annually, especially in countries like India, boosting market growth.

3. Government Initiatives and Awareness Programs

Government programs such as cataract elimination campaigns and eye care awareness initiatives are encouraging patients to undergo surgeries, thereby increasing product adoption.

4. Technological Advancements

Innovations in lens materials and designs, including multifocal and toric lenses, are improving surgical outcomes and expanding treatment options.

Market Restraints

The market faces certain limitations, including:

• Lack of reimbursement for premium IOLs in several countries
• High cost of advanced lenses
• Limited awareness about premium treatment options

These factors may restrict adoption, particularly in emerging economies.

Market Segmentation

By Type

• Monofocal Lenses: Dominated the market with a 64.41% share in 2026, due to affordability and widespread use.
• Premium Lenses: Includes multifocal and toric lenses, expected to witness strong growth due to advanced features.

By Material

• Foldable Lenses: Held a dominant 87.59% share in 2026, driven by ease of implantation and better performance.
• PMMA Lenses: Cost-effective option, widely used in certain regions.

By End-User

• Hospitals & Ambulatory Surgery Centers: Dominated with a 57.42% share in 2026, due to high volume of cataract procedures.
• Other segments include specialty clinics and research institutes.

Regional Insights

• North America: Largest market with USD 1.74 billion in 2025, projected to reach USD 1.85 billion in 2026, driven by advanced healthcare infrastructure.
• Europe: Valued at USD 1.48 billion in 2025, expected to reach USD 1.58 billion in 2026, supported by a high aging population.
• Asia Pacific: Reached USD 1.49 billion in 2025, projected to reach USD 1.61 billion in 2026, driven by increasing cataract cases and healthcare expansion.
• Latin America: Valued at USD 0.27 billion in 2025, expected to reach USD 0.29 billion in 2026.
• Middle East & Africa: Accounted for USD 0.15 billion in 2025, projected to reach USD 0.16 billion in 2026.

Competitive Landscape

The intraocular lens market is consolidated, with major players such as Alcon Inc., Johnson & Johnson Vision, Bausch & Lomb, HOYA, and Carl Zeiss Meditec AG leading the industry. These companies focus on product innovation, strategic collaborations, and expanding global distribution networks.

New product launches, such as advanced monofocal and extended depth of focus lenses, are strengthening their market positions.

Conclusion

The intraocular lens market is expected to witness steady growth, expanding from USD 5.14 billion in 2025 to USD 9.52 billion by 2034. This growth is driven by the rising prevalence of cataracts, increasing number of surgical procedures, and advancements in lens technology.

Although challenges such as high costs and limited reimbursement for premium products exist, growing awareness, government initiatives, and expanding healthcare infrastructure will continue to support market growth. Intraocular lenses will remain a vital component in modern ophthalmic care, improving vision outcomes and enhancing patient quality of life worldwide.

Segmentation By Type

• Monofocal
• Premium
  • Multifocal
  • Toric
  • Others

By Material

• Polymethylmethacrylate (PMMA)
• Foldable
  • Hydrophobic Acrylic
  • Hydrophilic Acrylic
  • Silicone & Collamer

By End-user

• Hospitals & Ambulatory Surgery Centers
• Specialty Clinics
• Academic & Research Institutes

By Geography

• North America (By Type, By Material, By End-user, and By Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Type, By Material, By End-user, and By Country/Sub-Region)
  • Germany (By Type)
  • France (By Type)
  • U.K. (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, By Material, By End-user, and By Country/Sub-Region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • South East Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America (By Type, By Material, By End-user, and By Country/Sub-Region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, By Material, By End-user, and By Country/Sub-Region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of Middle East & Africa (By Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Cataract Surgery, By Key Countries, 2025
• 4.2. Prevalence of Cataract, By Key Countries, 2025
• 4.3. Regulatory Scenario, By Key Countries
• 4.4. Overview of Government Cataract Initiatives
• 4.5. New Product Launches, By Key Players
• 4.6. Reimbursement Scenario For Key Countries
• 4.7. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.8. Impact of COVID-19 on the Global Intraocular Lens (IOL) Market

5. Global Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Monofocal
  • 5.1.2. Premium
    • 5.1.2.1. Multifocal
    • 5.1.2.2. Toric
    • 5.1.2.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Polymethylmethacrylate (PMMA)
  • 5.2.2. Foldable
    • 5.2.2.1. Hydrophobic Acrylic
    • 5.2.2.2. Hydrophilic Acrylic
    • 5.2.2.3. Silicone & Collamer
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & Ambulatory Surgery Centers
  • 5.3.2. Specialty Clinics
  • 5.3.3. Academic & Research Institutes
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Monofocal
  • 6.1.2. Premium
    • 6.1.2.1. Multifocal
    • 6.1.2.2. Toric
    • 6.1.2.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Polymethylmethacrylate (PMMA)
  • 6.2.2. Foldable
    • 6.2.2.1. Hydrophobic Acrylic
    • 6.2.2.2. Hydrophilic Acrylic
    • 6.2.2.3. Silicone & Collamer
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & Ambulatory Surgery Centers
  • 6.3.2. Specialty Clinics
  • 6.3.3. Academic & Research Institutes
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Type
  • 6.4.2. Canada
    • 6.4.2.1. By Type

7. Europe Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Monofocal
  • 7.1.2. Premium
    • 7.1.2.1. Multifocal
    • 7.1.2.2. Toric
    • 7.1.2.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Polymethylmethacrylate (PMMA)
  • 7.2.2. Foldable
    • 7.2.2.1. Hydrophobic Acrylic
    • 7.2.2.2. Hydrophilic Acrylic
    • 7.2.2.3. Silicone & Collamer
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & Ambulatory Surgery Centers
  • 7.3.2. Specialty Clinics
  • 7.3.3. Academic & Research Institutes
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. Germany
    • 7.4.1.1. By Type
  • 7.4.2. France
    • 7.4.2.1. By Type
  • 7.4.3. U.K.
    • 7.4.3.1. By Type
  • 7.4.4. Italy
    • 7.4.4.1. By Type
  • 7.4.5. Spain
    • 7.4.5.1. By Type
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Type
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Type

8. Asia Pacific Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Monofocal
  • 8.1.2. Premium
    • 8.1.2.1. Multifocal
    • 8.1.2.2. Toric
    • 8.1.2.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Polymethylmethacrylate (PMMA)
  • 8.2.2. Foldable
    • 8.2.2.1. Hydrophobic Acrylic
    • 8.2.2.2. Hydrophilic Acrylic
    • 8.2.2.3. Silicone & Collamer
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & Ambulatory Surgery Centers
  • 8.3.2. Specialty Clinics
  • 8.3.3. Academic & Research Institutes
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. China
    • 8.4.1.1. By Type
  • 8.4.2. Japan
    • 8.4.2.1. By Type
  • 8.4.3. India
    • 8.4.3.1. By Type
  • 8.4.4. Australia
    • 8.4.4.1. By Type
  • 8.4.5. South East Asia
    • 8.4.5.1. By Type
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Type

9. Latin America Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Monofocal
  • 9.1.2. Premium
    • 9.1.2.1. Multifocal
    • 9.1.2.2. Toric
    • 9.1.2.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Polymethylmethacrylate (PMMA)
  • 9.2.2. Foldable
    • 9.2.2.1. Hydrophobic Acrylic
    • 9.2.2.2. Hydrophilic Acrylic
    • 9.2.2.3. Silicone & Collamer
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & Ambulatory Surgery Centers
  • 9.3.2. Specialty Clinics
  • 9.3.3. Academic & Research Institutes
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
    • 9.4.1.1. By Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Type

10. Middle East & Africa Intraocular Lens (IOL) Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Monofocal
  • 10.1.2. Premium
    • 10.1.2.1. Multifocal
    • 10.1.2.2. Toric
    • 10.1.2.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Material
  • 10.2.1. Polymethylmethacrylate (PMMA)
  • 10.2.2. Foldable
    • 10.2.2.1. Hydrophobic Acrylic
    • 10.2.2.2. Hydrophilic Acrylic
    • 10.2.2.3. Silicone & Collamer
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & Ambulatory Surgery Centers
  • 10.3.2. Specialty Clinics
  • 10.3.3. Academic & Research Institutes
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
    • 10.4.1.1. By Type
  • 10.4.2. South Africa
    • 10.4.2.1. By Type
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Alcon Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Product
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. financials (Based on Availability)
  • 11.2.2. Bausch & Lomb Incorporated (Bausch Health Companies, Inc.)
    • 11.2.2.1. Overview
    • 11.2.2.2. Product
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. financials (Based on Availability)
  • 11.2.3. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
    • 11.2.3.1. Overview
    • 11.2.3.2. Product
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. financials (Based on Availability)
  • 11.2.4. HOYA Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Product
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. financials (Based on Availability)
  • 11.2.5. Rayner Group
    • 11.2.5.1. Overview
    • 11.2.5.2. Product
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. financials (Based on Availability)
  • 11.2.6. Hanita Lenses
    • 11.2.6.1. Overview
    • 11.2.6.2. Product
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. financials (Based on Availability)
  • 11.2.7. SIFI S.p.A
    • 11.2.7.1. Overview
    • 11.2.7.2. Product
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. financials (Based on Availability)
  • 11.2.8. Biotech
    • 11.2.8.1. Overview
    • 11.2.8.2. Product
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. financials (Based on Availability)
  • 11.2.9. STAAR SURGICAL
    • 11.2.9.1. Overview
    • 11.2.9.2. Product
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. financials (Based on Availability)